Balance Sheet L'Oréal

Equities

OR

FR0000120321

Personal Products

Market Closed - Euronext Paris Other stock markets 16:55:00 20/05/2026 BST			After hours 20:59:59
360.20 ^EUR	+0.84%		361.25	+0.29%

05-17	Coty still in recovery mode
05-15	Less is more: Marc Jacobs sale shows LVMH cutting complexity as downturn drags on	RE

fcfe925a29027b7669bc86a3a7.-UIPMIwu1mFW5DnkFTEdqjkwwo24Sx-_E_1OO-Tdi-M.kBZ-U-Je4S8MswGrXVVy5k8Gs_fRP1bmXLo_fquVs6K0KUIC-hqbCRq0DQ

Published financial data: L'ORÉAL

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	32.29B	38.26B	41.18B	43.49B	44.05B
Total Revenues	32.29B	38.26B	41.18B	43.49B	44.05B
Cost of Goods Sold, Total	8.43B	10.58B	10.77B	11.23B	11.31B
Gross Profit	23.85B	27.68B	30.42B	32.26B	32.74B
Selling General & Admin Expenses, Total	16.68B	19.09B	20.99B	22.23B	22.48B
R&D Expenses	1.03B	1.14B	1.29B	1.35B	1.38B
Other Operating Expenses, Total	17.7B	20.23B	22.27B	23.58B	23.86B
Operating Income	6.15B	7.45B	8.14B	8.68B	8.88B
Interest Expense, Total	-38M	-70.4M	-227M	-373M	-366M
Interest And Investment Income	397M	538M	583M	593M	520M
Net Interest Expenses	359M	468M	356M	220M	154M
Income (Loss) On Equity Invest.	600K	1.4M	200K	-1.3M	-5.5M
Other Non Operating Income (Expenses)	-30.1M	-65.8M	-46.6M	-25.8M	-29M
EBT, Excl. Unusual Items	6.48B	7.85B	8.45B	8.87B	9B
Restructuring Charges	-150M	-58M	-88.5M	-237M	-208M
Merger & Related Restructuring Charges	-14.3M	-	-46M	-20.7M	-49.5M
Impairment of Goodwill	-255M	-	-250M	-	-
Gain (Loss) On Sale Of Assets	-400K	-122M	-6.7M	-15.2M	-37.7M
Asset Writedown	-82.8M	-39M	-20.6M	-50.8M	-
Legal Settlements	45.6M	-	-	-99.9M	-
Other Unusual Items	24.2M	-22.5M	-38.1M	-14M	-210M
EBT, Incl. Unusual Items	6.05B	7.61B	8B	8.43B	8.5B
Income Tax Expense	1.45B	1.9B	1.81B	2.02B	2.36B
Earnings From Continuing Operations	4.6B	5.71B	6.19B	6.42B	6.13B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	4.6B	5.71B	6.19B	6.42B	6.13B
Minority Interest	-5.1M	-6M	-6.5M	-7.8M	-6.5M
Net Income - (IS)	4.6B	5.71B	6.18B	6.41B	6.13B
Net Income to Common Incl Extra Items	4.6B	5.71B	6.18B	6.41B	6.13B
Net Income to Common Excl. Extra Items	4.6B	5.71B	6.18B	6.41B	6.13B
Per Share Items
Net EPS - Basic	8.24	10.65	11.55	11.99	11.48
Basic EPS - Continuing Operations	8.24	10.65	11.55	11.99	11.48
Basic Weighted Average Shares Outstanding	558M	536M	535M	534M	534M
Net EPS - Diluted	8.21	10.61	11.52	11.95	11.44
Diluted EPS - Continuing Operations	8.21	10.61	11.52	11.95	11.44
Diluted Weighted Average Shares Outstanding	560M	538M	537M	536M	535M
Normalized Basic EPS	7.25	9.15	9.85	10.36	10.53
Normalized Diluted EPS	7.23	9.12	9.82	10.33	10.5
Dividend Per Share	4.8	6	6.6	7	7.2
Payout Ratio	51.16	47.14	55.39	56.41	63.93
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	6.93B	8.29B	9.01B	9.64B	9.89B
EBITA	6.22B	7.46B	8.21B	8.74B	8.94B
EBIT	6.15B	7.45B	8.14B	8.68B	8.88B
Effective Tax Rate - (Ratio)	23.9	24.95	22.63	23.9	27.81
Total Current Taxes	1.36B	2B	1.91B	2.05B	2.29B
Total Deferred Taxes	83.6M	-96.5M	-95.3M	-37.4M	68.2M
Normalized Net Income	4.04B	4.9B	5.28B	5.54B	5.62B
Non-Cash Pension Expense	-15.5M	-9.1M	-11.3M	2.1M	3.3M
Supplemental Operating Expense Items
Advertising Expense	10.59B	12.06B	13.36B	14.01B	14.18B
Selling and Marketing Expenses	10.59B	12.06B	13.36B	14.01B	14.18B
Research And Development Expense From Footnotes	1.03B	1.14B	1.29B	1.35B	1.38B
Stock-Based Comp., Other (Total)	155M	169M	168M	239M	248M
Total Stock-Based Compensation	155M	169M	168M	239M	248M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.71B	2.62B	4.29B	4.05B	9.86B
Short Term Investments	4.8M	23.1M	33.1M	29.1M	-
Total Cash And Short Term Investments	2.72B	2.64B	4.32B	4.08B	9.86B
Accounts Receivable, Total	4.02B	4.76B	5.09B	5.6B	5.5B
Other Receivables	844M	1.01B	1.06B	902M	898M
Total Receivables	4.87B	5.76B	6.15B	6.5B	6.4B
Inventory	3.17B	4.08B	4.48B	4.63B	4.54B
Prepaid Expenses	504M	617M	656M	522M	599M
Other Current Assets, Total	822M	951M	717M	735M	793M
Total Current Assets	12.08B	14.05B	16.33B	16.47B	22.2B
Gross Property Plant And Equipment	11.53B	11.8B	12.7B	13.39B	13.14B
Accumulated Depreciation	-6.75B	-6.83B	-7.14B	-7.42B	-7.26B
Net Property Plant And Equipment	4.77B	4.96B	5.56B	5.97B	5.88B
Long-term Investments	10.79B	11.13B	11.16B	14.34B	12.52B
Goodwill	11.07B	11.72B	13.1B	13.38B	14.47B
Other Intangibles, Total	3.46B	3.64B	4.29B	4.59B	5.07B
Loans Receivable Long-Term	135M	139M	171M	156M	184M
Deferred Tax Assets Long-Term	696M	801M	921M	973M	963M
Other Long-Term Assets, Total	-100K	400M	330M	471M	541M
Total Assets	43.01B	46.84B	51.86B	56.35B	61.82B
Liabilities
Accounts Payable, Total	6.07B	6.35B	6.35B	6.47B	6.73B
Accrued Expenses, Total	1.63B	1.85B	2.18B	2.16B	2.18B
Short-term Borrowings	2.63B	877M	67M	36.3M	54.1M
Current Portion of Long-Term Debt	1.99B	136M	2.02B	1.34B	1.99B
Current Portion of Leases	423M	407M	460M	469M	434M
Current Income Taxes Payable	269M	264M	208M	275M	255M
Other Current Liabilities	3.58B	3.84B	3.62B	3.88B	3.72B
Total Current Liabilities	16.58B	13.72B	14.9B	14.64B	15.37B
Long-Term Debt	10.7M	3.02B	4.75B	5.19B	8.07B
Long-Term Leases	1.25B	1.21B	1.39B	1.46B	1.36B
Pension & Other Post Retirement Benefits	361M	458M	562M	669M	684M
Deferred Tax Liability Non Current	810M	906M	847M	964M	1.01B
Other Non Current Liabilities	408M	344M	324M	301M	321M
Total Liabilities	19.42B	19.66B	22.77B	23.22B	26.82B
Common Stock, Total	112M	107M	107M	107M	107M
Additional Paid In Capital	3.27B	3.37B	3.37B	3.44B	3.51B
Retained Earnings	23.69B	17.38B	19.98B	22.55B	6.13B
Treasury Stock	-8.94B	-	-	-	-
Comprehensive Income and Other	5.46B	6.32B	5.61B	7.03B	25.21B
Total Common Equity	23.59B	27.18B	29.07B	33.13B	34.95B
Minority Interest	6.9M	8M	7.3M	4.5M	50.6M
Total Equity	23.59B	27.19B	29.08B	33.14B	35B
Total Liabilities And Equity	43.01B	46.84B	51.86B	56.35B	61.82B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	535M	535M	535M	534M	534M
ECS Total Common Shares Outstanding	535M	535M	535M	534M	534M
Book Value / Share	44.05	50.78	54.37	62.01	65.48
Tangible Book Value	9.05B	11.82B	11.68B	15.16B	15.41B
Tangible Book Value Per Share	16.9	22.09	21.85	28.37	28.87
Total Debt	6.3B	5.65B	8.69B	8.5B	11.92B
Net Debt	3.58B	3.01B	4.37B	4.41B	2.05B
Debt Equivalent of Unfunded Proj. Benefit Obligation	361M	57.8M	232M	198M	143M
Minority Interest, Total (Incl. Fin. Div)	6.9M	8M	7.3M	4.5M	50.6M
Equity Method Investments, Total	9.9M	18.4M	27M	126M	376M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	839M	1.18B	1.16B	1.1B	1.12B
Inventories - Finished Goods, Total	2.77B	3.38B	3.83B	4.02B	3.92B
Land - (BS)	2.38B	2.49B	2.66B	2.8B	2.78B
Machinery, Total	3.73B	3.92B	4.1B	4.26B	4.34B
Full Time Employees	85.41K	87.37K	94.6K	76.26K	79.03K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	48.7M	36.8M	32.8M	29.2M	27M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	4.6B	5.71B	6.18B	6.41B	6.13B
Depreciation & Amortization - CF	1.11B	1.25B	1.22B	1.38B	1.44B
Amortization of Goodwill and Intangible Assets - (CF)	70.3M	14.2M	71.2M	59.5M	53M
Depreciation & Amortization, Total	1.18B	1.27B	1.29B	1.44B	1.49B
Amortization of Deferred Charges, Total - (CF)	194M	166M	155M	145M	158M
Minority Interest in Earnings - (CF)	5.1M	6M	6.5M	7.8M	6.5M
(Gain) Loss From Sale Of Asset	500K	7.6M	6.9M	15.2M	37.8M
Asset Writedown & Restructuring Costs	83M	39M	-	1.6M	-
(Income) Loss On Equity Investments - (CF)	1.3M	-500K	-200K	2.9M	6.7M
Stock-Based Compensation (CF)	155M	169M	168M	239M	248M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	422M	-73.3M	184M	252M	251M
Change In Accounts Receivable	-407M	-718M	-427M	-507M	-153M
Change In Inventories	-373M	-865M	-438M	-121M	-142M
Change In Accounts Payable	1.09B	248M	139M	78.8M	538M
Change in Other Net Operating Assets	-218M	324M	332M	322M	83.6M
Cash from Operations	6.73B	6.28B	7.6B	8.29B	8.66B
Capital Expenditure	-1.08B	-1.34B	-1.49B	-1.64B	-1.5B
Sale of Property, Plant, and Equipment	14.5M	9.2M	12.8M	13.6M	5.7M
Cash Acquisitions	-456M	-747M	-2.5B	-149M	-2.43B
Investment in Marketable and Equity Securities, Total	-117M	-143M	-171M	-1.93B	2.51B
Other Investing Activities, Total	-	-100K	100K	100K	100K
Cash from Investing	-1.63B	-2.22B	-4.14B	-3.7B	-1.41B
Short Term Debt Issued, Total	3.94B	-	-	-	-
Long-Term Debt Issued, Total	-	3.02B	3.57B	1.53B	4.06B
Total Debt Issued	3.94B	3.02B	3.57B	1.53B	4.06B
Short Term Debt Repaid, Total	-	-3.56B	-824M	-1.78B	-610M
Long-Term Debt Repaid, Total	-396M	-447M	-431M	-482M	-476M
Total Debt Repaid	-396M	-4.01B	-1.25B	-2.26B	-1.09B
Issuance of Common Stock	5.8M	103M	1.5M	69.9M	65.6M
Repurchase of Common Stock	-10.06B	-502M	-503M	-498M	-502M
Common Dividends Paid	-2.35B	-2.69B	-3.43B	-3.61B	-3.92B
Common & Preferred Stock Dividends Paid	-2.35B	-2.69B	-3.43B	-3.61B	-3.92B
Other Financing Activities, Total	-	-100K	-	-13.9M	-16.3M
Cash from Financing	-8.86B	-4.08B	-1.61B	-4.79B	-1.4B
Foreign Exchange Rate Adjustments	77.4M	-70.7M	-176M	-32.8M	-39.2M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-100K
Net Change in Cash	-3.69B	-96.1M	1.67B	-236M	5.81B
Supplemental Items
Cash Interest Paid	1.7M	28.4M	185M	382M	358M
Cash Income Tax Paid (Refund)	1.26B	2.1B	2B	2.02B	2.39B
Levered Free Cash Flow	4.72B	3.58B	4.53B	5.42B	5.91B
Unlevered Free Cash Flow	4.74B	3.62B	4.67B	5.66B	6.14B
Change In Net Working Capital	-444M	1.29B	547M	-49.8M	-185M
Net Debt Issued / Repaid	3.54B	-991M	2.31B	-729M	2.97B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.88	10.36	10.31	10.02	9.4
Return on Total Capital	12.51	14.85	14.41	13.66	12.54
Return On Equity %	17.5	22.5	22	20.63	18
Return on Common Equity	17.49	22.48	21.99	20.6	18
Margin Analysis
Gross Profit Margin %	73.88	72.35	73.86	74.18	74.32
SG&A Margin	51.65	49.91	50.96	51.12	51.02
EBITDA Margin %	21.45	21.67	21.88	22.17	22.46
EBITA Margin %	19.27	19.51	19.94	20.09	20.28
EBIT Margin %	19.05	19.47	19.77	19.95	20.16
Income From Continuing Operations Margin %	14.25	14.93	15.03	14.76	13.92
Net Income Margin %	14.24	14.92	15.02	14.74	13.91
Net Avail. For Common Margin %	14.24	14.92	15.02	14.74	13.91
Normalized Net Income Margin	12.53	12.81	12.81	12.73	12.76
Levered Free Cash Flow Margin	14.62	9.36	11	12.47	13.42
Unlevered Free Cash Flow Margin	14.69	9.47	11.34	13	13.94
Asset Turnover
Asset Turnover	0.75	0.85	0.83	0.8	0.75
Fixed Assets Turnover	6.78	7.86	7.83	7.55	7.44
Receivables Turnover (Average Receivables)	8.57	8.72	8.36	8.13	7.94
Inventory Turnover (Average Inventory)	2.89	2.92	2.52	2.46	2.47
Short Term Liquidity
Current Ratio	0.73	1.02	1.1	1.13	1.44
Quick Ratio	0.46	0.61	0.7	0.72	1.06
Operating Cash Flow to Current Liabilities	0.41	0.46	0.51	0.57	0.56
Days Sales Outstanding (Average Receivables)	42.57	41.86	43.64	45	45.99
Days Outstanding Inventory (Average Inventory)	126.44	125.03	145.12	148.53	147.98
Average Days Payable Outstanding	221.52	197.17	207.38	206.18	214.52
Cash Conversion Cycle (Average Days)	-52.51	-30.28	-18.61	-12.64	-20.55
Long Term Solvency
Total Debt/Equity	26.7	20.79	29.89	25.64	34.04
Total Debt / Total Capital	21.08	17.21	23.01	20.4	25.4
LT Debt/Equity	5.33	15.56	21.12	20.05	26.95
Long-Term Debt / Total Capital	4.21	12.88	16.26	15.96	20.1
Total Liabilities / Total Assets	45.15	41.96	43.92	41.2	43.38
EBIT / Interest Expense	161.85	105.83	35.91	23.24	24.28
EBITDA / Interest Expense	192.97	123.85	41.62	27.09	28.37
(EBITDA - Capex) / Interest Expense	164.67	104.77	35.05	22.7	24.28
Total Debt / EBITDA	0.86	0.65	0.92	0.84	1.15
Net Debt / EBITDA	0.49	0.35	0.46	0.44	0.2
Total Debt / (EBITDA - Capex)	1.01	0.77	1.09	1	1.34
Net Debt / (EBITDA - Capex)	0.57	0.41	0.55	0.52	0.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.35	18.5	7.64	5.6	1.3
Gross Profit, 1 Yr. Growth %	16.59	16.05	9.87	6.06	1.48
EBITDA, 1 Yr. Growth %	13.58	19.69	8.67	7.49	2.62
EBITA, 1 Yr. Growth %	18.44	20	10.02	6.64	2.29
EBIT, 1 Yr. Growth %	18.37	21.14	9.27	6.58	2.38
Earnings From Cont. Operations, 1 Yr. Growth %	29	24.13	8.37	3.65	-4.41
Net Income, 1 Yr. Growth %	29.01	24.13	8.37	3.63	-4.39
Normalized Net Income, 1 Yr. Growth %	18.1	21.21	7.61	4.93	1.52
Diluted EPS Before Extra, 1 Yr. Growth %	29.5	29.23	8.58	3.73	-4.27
Accounts Receivable, 1 Yr. Growth %	14.52	18.27	7.09	10	-1.81
Inventory, 1 Yr. Growth %	18.35	28.81	9.88	3.3	-1.87
Net Property, Plant and Equip., 1 Yr. Growth %	0.49	3.99	12	7.29	-1.51
Total Assets, 1 Yr. Growth %	-1.36	8.91	10.7	8.67	9.7
Tangible Book Value, 1 Yr. Growth %	-40.17	30.64	-1.15	29.71	1.68
Common Equity, 1 Yr. Growth %	-18.65	15.23	6.98	13.96	5.49
Cash From Operations, 1 Yr. Growth %	4.26	-6.69	21.13	8.96	4.48
Capital Expenditures, 1 Yr. Growth %	10.57	24.93	10.83	10.28	-8.92
Levered Free Cash Flow, 1 Yr. Growth %	1.84	-24.15	26.49	20.77	8.98
Unlevered Free Cash Flow, 1 Yr. Growth %	1.27	-23.6	28.86	22.11	8.53
Dividend Per Share, 1 Yr. Growth %	20	25	10	6.06	2.86
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.96	16.91	12.94	6.61	3.43
Gross Profit, 2 Yr. CAGR %	4.58	16.32	12.92	7.95	3.75
EBITDA, 2 Yr. CAGR %	3.28	16.59	14.05	7.59	5.03
EBITA, 2 Yr. CAGR %	5.34	19.22	14.9	7.9	4.44
EBIT, 2 Yr. CAGR %	5.41	19.75	15.05	7.92	4.46
Earnings From Cont. Operations, 2 Yr. CAGR %	10.7	26.54	15.98	5.98	-0.46
Net Income, 2 Yr. CAGR %	10.72	26.55	15.98	5.97	-0.46
Normalized Net Income, 2 Yr. CAGR %	5.26	19.64	14.21	6.26	3.21
Diluted EPS Before Extra, 2 Yr. CAGR %	11.03	29.36	18.46	6.13	-0.35
Accounts Receivable, 2 Yr. CAGR %	-0.81	16.38	12.54	8.53	3.92
Inventory, 2 Yr. CAGR %	4.13	23.47	18.97	6.54	0.68
Net Property, Plant and Equip., 2 Yr. CAGR %	-7.14	2.23	7.92	9.62	2.79
Total Assets, 2 Yr. CAGR %	-0.91	3.65	9.8	9.68	9.19
Tangible Book Value, 2 Yr. CAGR %	-26.33	-11.59	13.64	13.23	14.85
Common Equity, 2 Yr. CAGR %	-10.46	-3.18	11.03	10.41	9.64
Cash From Operations, 2 Yr. CAGR %	3.65	-1.37	6.31	14.88	6.69
Capital Expenditures, 2 Yr. CAGR %	-6.54	17.53	17.67	10.55	0.22
Levered Free Cash Flow, 2 Yr. CAGR %	2.8	-12.11	-2.05	22.39	15.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	2.52	-12.04	-0.78	24.24	15.58
Dividend Per Share, 2 Yr. CAGR %	11.66	22.47	17.26	8.01	4.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.22	8.6	13.73	10.44	4.81
Gross Profit, 3 Yr. CAGR %	6.76	8.27	14.13	10.59	5.75
EBITDA, 3 Yr. CAGR %	5.61	8.48	13.89	11.65	5.9
EBITA, 3 Yr. CAGR %	7.69	10.02	16.07	11.99	6
EBIT, 3 Yr. CAGR %	7.77	10.41	16.15	12.15	6.04
Earnings From Cont. Operations, 3 Yr. CAGR %	5.68	15.01	20.17	11.71	2.4
Net Income, 3 Yr. CAGR %	5.68	15.02	20.17	11.71	2.4
Normalized Net Income, 3 Yr. CAGR %	7.07	10.33	15.49	11.03	4.66
Diluted EPS Before Extra, 3 Yr. CAGR %	5.86	16.79	22.03	13.33	2.54
Accounts Receivable, 3 Yr. CAGR %	0.32	5.18	13.19	11.69	4.97
Inventory, 3 Yr. CAGR %	3.92	11.78	18.76	13.5	3.66
Net Property, Plant and Equip., 3 Yr. CAGR %	9.61	-3.57	5.39	7.71	5.77
Total Assets, 3 Yr. CAGR %	3.8	2.26	5.94	9.42	9.69
Tangible Book Value, 3 Yr. CAGR %	-14.04	-10.83	-8.24	18.76	9.24
Common Equity, 3 Yr. CAGR %	-4.32	-2.61	0.09	12	8.75
Cash From Operations, 3 Yr. CAGR %	8.33	0.08	5.62	7.19	11.3
Capital Expenditures, 3 Yr. CAGR %	-8.77	2.95	15.25	15.15	3.64
Levered Free Cash Flow, 3 Yr. CAGR %	13.55	-7.11	-0.77	4.72	17.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.49	-7.05	-0.1	6.03	18.79
Dividend Per Share, 3 Yr. CAGR %	7.63	15.94	18.17	13.4	6.27
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.32	8.01	8.86	7.8	9.49
Gross Profit, 5 Yr. CAGR %	5.97	8.2	9.18	8.14	9.86
EBITDA, 5 Yr. CAGR %	4.83	7.32	8.91	8.22	10.16
EBITA, 5 Yr. CAGR %	6.76	9.8	10.52	9.28	11.21
EBIT, 5 Yr. CAGR %	6.52	9.76	10.62	9.41	11.32
Earnings From Cont. Operations, 5 Yr. CAGR %	8.34	8.35	9.68	11.31	11.45
Net Income, 5 Yr. CAGR %	8.16	9.77	9.68	11.31	11.45
Normalized Net Income, 5 Yr. CAGR %	6.01	9.44	9.87	8.68	10.41
Diluted EPS Before Extra, 5 Yr. CAGR %	8.5	9.37	10.73	12.4	12.53
Accounts Receivable, 5 Yr. CAGR %	0.4	3.92	5.04	6.51	9.39
Inventory, 5 Yr. CAGR %	3.25	10.34	9.7	9.65	11.17
Net Property, Plant and Equip., 5 Yr. CAGR %	4.91	6.81	8.93	1.5	4.34
Total Assets, 5 Yr. CAGR %	3.84	5.8	6.16	5.16	7.23
Tangible Book Value, 5 Yr. CAGR %	-6.3	-2.42	-3.88	-1.89	0.38
Common Equity, 5 Yr. CAGR %	-0.76	1.84	1.55	2.41	3.81
Cash From Operations, 5 Yr. CAGR %	7.42	3.85	7.52	5.76	6.05
Capital Expenditures, 5 Yr. CAGR %	-4.23	1.23	1	5.93	8.99
Levered Free Cash Flow, 5 Yr. CAGR %	12.67	1.95	7.03	3.95	4.99
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.63	2.06	7.55	4.61	5.56
Dividend Per Share, 5 Yr. CAGR %	7.78	11.07	11.38	12.7	12.47